Age-stratified utility of NT-proBNP testing as part of a blind Emergency Department shortness of breath orderset (Jan-Dec 2019)
European Journal of Heart Failure
; 24:187-188, 2022.
Article
in English
| EMBASE | ID: covidwho-1995534
ABSTRACT
Background:
NT-proBNP was added to our emergency department (ED) triage blind 'shortness of breath (SOB) orderset' for presenters aged >70. Evidence-based thresholds for acute heart failure (HF) diagnosis are >900/1800 pg/ml for ages 50-75/>75 respectively (1.2);their utility in contemporary practice is uncertain.Purpose:
To assess the relation between blind NT-proBNP testing in this setting and (1) coded discharge diagnosis stratified by age, and (2) all-cause mortality at medium-term follow-up.Methods:
We retrieved all ED 'SOB' blood ordersets (1.1.2019-31.12.2019), including NT-proBNP, Hb, electrolytes, creatinine, troponin, CRP, d-dimer, and coded discharge diagnoses. Multivariate logistic regression models for all-cause survival (at 9.9.2021) were assessed.Results:
There were 638 presentations (median age 76.1), unexpectedly including 198 <70 years. Modal and median lengths of stay were 0 and 1 day respectively. Stratified by age (<60, 60-69, 70-74, 75-79, 80-84, ≥85y), the proportion with HF coded as primary discharge diagnosis (5, 7, 9, 17, 18, 25% respectively) and all-comer all-cause mortality at 2.2±0.3 years (13, 42, 40, 48, 48, 49%) steadily increased (Table;orderset variables presented as median (inter-quartile range)). Median NT-proBNP was 3672, 2667, and 321 pg/ml when HF was in the primary, secondary, or neither coded discharge diagnosis field respectively;2.2-year-all-cause mortality was 54%, 60%, and 35%. In those with a primary HF discharge code, 77% of 349 presenters ≥75y and 88% of 231 aged 50-74 had NT-proBNP >1800/900 pg/ml respectively. In those without an HF code, 26% in both age cohorts had NT-proBNP >1800/900 pg/ml (dotted lines in Figure, panels A/B, respectively represent NT-proBNP thresholds). Independent predictors of all-cause mortality for patients with a primary or secondary HF code were ln(NT-proBNP) (OR 1.26, 95% CI 1-1.59) and serum Na+ (OR 0.93, 0.88-0.99);for patients without an HF code, these were serum K+ (1.87, 1.21-2.88), ln(NT-proBNP) (1.35, 1.15-1.58), ln(CRP) (1.18, 1.02-1.36), length of stay (1.08, 1.03-1.12), and age (1.03, 1.01-1.06). (Figure Presented)Conclusion:
HF detection with NT-proBNP in a blind SOB orderset showed increasing sensitivity with age with the best specificity >75 years. Most presenters stayed ≤1 day, so blind testing at triage facilitates HF detection. NT-proBNP independently predicted 2.2-year-all-cause mortality irrespective of discharge HF coding. This is notable as the commonest non-HF causes of acute SOB are prognostically important at >70 years and follow-up occurred through the Covid-19 pandemic. The findings may reflect disease severity in patients without HF, but also suggest that discharge HF coding status does not identify all those with prognostically relevant HF.
amino terminal pro brain natriuretic peptide; C reactive protein; creatinine; D dimer; electrolyte; endogenous compound; sodium ion; troponin; adult; aged; all cause mortality; conference abstract; controlled study; coronavirus disease 2019; diagnosis; dyspnea; emergency ward; follow up; heart failure; human; human tissue; length of stay; middle aged; overall survival; pandemic; patient triage; sensitivity and specificity
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
European Journal of Heart Failure
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS